To better understand the potential of drug repurposing in COVID-19, we analyzed control
strategies over essential host factors for SARS-CoV-2 infection. We constructed …

Abstract Coronavirus Disease-2019 (COVID-19) is an infectious disease caused by the
SARS-CoV-2 virus. Various studies exist about the molecular mechanisms of viral infection …

Abstract The Coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus
needs a fast recognition of effective drugs to save lives. In the COVID-19 situation, finding …

Background Currently, no proven effective drugs for the novel coronavirus disease COVID-
19 exist and despite widespread vaccination campaigns, we are far short from herd …

The novelty of new human coronavirus COVID-19/SARS-CoV-2 and the lack of effective
drugs and vaccines gave rise to a wide variety of strategies employed to fight this worldwide …

The COVID-19 disease caused by the SARS-CoV-2 virus is a health crisis worldwide. While
developing novel drugs and vaccines is long, repurposing existing drugs against COVID-19 …

Abstract Coronavirus disease 2019 (COVID-19) is caused by a novel virus named Severe
Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). This virus induced a large …

The coronavirus disease 2019 pandemic accelerated drug/vaccine development processes,
integrating scientists all over the globe to create therapeutic alternatives against this virus. In …

We present two machine learning approaches for drug repurposing. While we have
developed them for COVID-19, they are disease-agnostic. The two methodologies are …

The 2019 novel coronavirus (SARS-CoV-2) pandemic has resulted in more than a million
deaths, high morbidities, and economic distress worldwide. There is an urgent need to …